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Abstract 
Although Merlin function as a tumor suppressor 
and regulator of mitogenic signaling networks such 
as the Ras/rac, Akt or Hippo pathways is well 
documented,in mammals as well as in insects, its 
role during cell cycle progression remains unclear. 
In this study, using a combination of approaches, 
including FACS analysis, time-lapse imaging, 
immunofluorescence microscopy and co-
immunoprecipitation, we show that Ser-518 of 
Merlin is a substrate of the Aurora A kinase during 
mitosis and that its phosphorylation facilitates the 
phosphorylation of a newly discovered site, Thr-
581. We found that the expression in Hela cells of 
a Merlin variant that is phosphorylation-defective 
on both sites leads to a defect in centrosomes and 
mitotic spindles positioning during metaphase and 
delays the transition from metaphase to anaphase. 
We also show that the dual mitotic 
phosphorylation not only reduces Merlin binding 
to microtubules but also timely modulates Ezrin 
interaction with the cytoskeleton. Finally, we 
identify several point mutants of Merlin associated 
with Neurofibromatosis type 2 that display an 
aberant phosphorylation profile along with 
defective α-tubulin binding properties. Altogether, 
our findings of an Aurora A–mediated interaction 
of Merlin with α-tubulin and Ezrin suggest a 
potential role for Merlin in cell cycle progression. 
Introduction  
 http://www.jbc.org/cgi/doi/10.1074/jbc.RA118.006937The latest version is at 
JBC Papers in Press. Published on July 11, 2019 as Manuscript RA118.006937
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The loss of Merlin expression results in tumor 
development in humans, a condition known as 
Neurofibromatosis type 2 (1-3). Merlin, the 
product of the NF2 tumor suppressor gene, inhibits 
cell proliferation by regulating signaling mediated 
by Rac1 and Ras GTPases or by mTorc1 and 2. At 
the plasma membrane, Merlin attenuates growth 
factor receptors expression and activity in both 
Drosophila and mammal (4-9). In addition, Merlin 
exerts its growth suppressive function in the 
nucleus where it inhibits the DCAF ubiquitin 
ligase activity (10). Finally, Merlin is a major 
regulator of the Hippo signaling pathway by 
inhibiting the nuclear accumulation of the co-
transcription factor Yap and Taz in various 
organisms (11, 12). Although these mechanisms 
initially appeared distinct, cross talks were 
identified between several of them (13-15).  
How Merlin modulates mitogenic signaling is 
extensively studied. In contrast, little information 
is available on a possible role in regulating cell 
cycle progression. In glioma and osteosarcoma cell 
lines, Merlin is nuclear early in G1 and gets 
exported toward the plasma membrane before S 
phase entry (16). Also, an interaction between 
Merlin and HEI10 was reported. HEI10 is involved 
in the regulation of cyclin B levels (17). However, 
no specific role of its interaction with Merlin was 
identified in the control of cell cycle progression. 
More recently Hebert et al., demonstrated that 
Merlin regulates polarized cell division by 
restricting the cortical distribution of Ezrin 
necessary for centrosome positioning and proper 
orientation of cell division (18). Indeed, Ezrin, 
Radixin and Moesin (ERM) have been implicated 
in several aspects of mitotic progression. In 
Drosophila cells, Moesin activation by 
phosphorylation during mitosis increases the 
cortical rigidity necessary for proper spindle 
morphogenesis and chromosome alignment (19, 
20). Moesin also regulates spindle length during 
metaphase and cell shape at a later stage of mitosis 
(21). In mammalian cells, the phosphorylation of 
the ERM by the kinase Slk during mitosis is key to 
the proper orientation of spindle (22). Interestingly, 
Merlin was shown to directly bind to microtubules 
and promote their stabilization (23, 24) but the 
functional consequences, were not investigated, 
notably during mitosis. 
These observations suggest that Merlin plays a role 
in cell cycle progression and more specifically 
during mitosis. In the present study, we show that 
Merlin is a substrate for Aurora A kinase on the 
main regulatory serine 518, during mitosis. This 
event facilitates the phosphorylation of a second, 
newly discovered site at position 581 that is 
specific of Merlin isoform 1. When Merlin dual 
phosphorylation is compromised, it leads to a 
defect in the stabilization of mitotic spindle 
orientation prior to metaphase, delaying the onset 
of anaphase. At the mechanistic level, we show 
that phosphorylation on S518 controls Merlin 
interaction with α-tubulin whereas T581 
phosphorylation modulates Merlin binding to 
Ezrin and subsequently Ezrin interactions with 
both actin and α-tubulin. Importantly, specific 
patient mutations affecting the FERM (Four point 
one Ezrin Radixin Moesin) domain of Merlin 
result in abnormal phosphorylation profile and α-
tubulin binding properties, in some case associated 
with a delay in mitotic progression.  Altogether our 
observations suggest that tight regulation of Merlin 
by Aurora A kinase is involved in mitotic 
progression via regulated binding to α−tubulin and 
Ezrin and is compromised by mutations found in 
Neurofibromatosis type 2 patients. 
Results  
Aurora A binds and phosphorylates Merlin in 
vitro and in vivo during mitosis 
The Aurora A kinase phosphorylates a variety of 
substrates during the cell cycle progression. The 
phosphorylation sites contain a conserved arginine 
in -2 position relative to the target serine residue, 
and leucine is frequently found in -1 (25). A close 
examination of the sequence surrounding serine 
518 of Merlin suggests a phosphorylation site for 
Aurora A, with arginine and a leucine in position 
516 and 517 respectively (Figure 1A). To test if 
Merlin could be a substrate for Aurora A in vitro, 
GFP-Merlin was immunoprecipitated from 
interphasic HEK293 cells, dephosphorylated with 
alkaline phosphatase and then incubated with 
recombinant GST-Aurora A. The same procedure 
was performed with GFP-Merlin mutant S518A, as 
a negative control. Using a specific antibody to p-
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S518, we could show that Aurora A efficiently 
phosphorylates this site in vitro (Figure 1B).  
Endogenous phospho-Merlin could not 
reproducibly be detected in total extracts from 
Hela cells, likely due to a low affinity of the pS518 
antibody and low levels of Merlin expression. 
Therefore, we generated Hela cells overexpressing 
Merlin isoform 1 under the tet-inducible promoter 
(Supplementary Figure 1A). Mitotic extracts were 
prepared from detached mitotic cells following 
overnight nocodazole block. The remaining 
attached cells were collected as interphasic 
population. As presented in Figure 1C, the 
phosphorylation of S518 was much higher (more 
than 5 times) in mitosis than during interphase.  
Mitotic Hela cells overexpressing Merlin isoform I  
were then treated with the Aurora A specific 
inhibitor MLN8054. We observed a clear 
reduction of Merlin phosphorylation on S518 
(Figure 1D). On the contrary, Aurora B inhibitor 
ZM4474 (Figure 1 E) had no effect. To confirm 
these results on endogenous Merlin, we treated 
mitotic HEK293 cells, expressing higher levels of 
Merlin than Hela cells, with MLN8054. We 
observed that S518 phosphorylation of 
immunoprecipitated Merlin dropped by 80% when 
compared to untreated cells (Figure 1F).  
Finally, we could co-precipitate endogenous 
Aurora A kinase with GFP-Merlin from mitotic 
extracts. Interestingly, although the S518 
phosphorylation site is close to the C-terminal end, 
the binding site of Aurora A lies within the FERM 
domain (Figure 1G). Aurora A did not co-
immunoprecipitate with the patient-derived Merlin 
∂2-3 mutant lacking amino acids 38 to 121 of the 
FERM domain (26) (Figure 1H) and the 
phosphorylation of S518 was drastically reduced in 
mitosis when compared to WT Merlin (Figure 1I). 
Altogether, our results demonstrate that Merlin is a 
bona fide substrate for Aurora A during mitosis.  
A new site is phosphorylated during mitosis and 
is specific of Merlin isoform 1 
A search for new phosphorylation sites of Merlin, 
by mass spectrometry, identified T581 in extracts 
from 293 HEK cells (Figure 2A). S518 and T581 
were the two strongest peaks visible by a 
proteomic approach. Interestingly, T581 is specific 
of Merlin isoform 1 (Figure 2B). We raised a 
specific antibody against a peptide containing the 
phosphorylated T581. By western-blot, a weak 
signal was observed in asynchronous population 
but only when Merlin was overexpressed. The 
signal was abolished when T581 was changed for 
an alanine demonstrating the specificity of the 
antibody (Figure 2C). As was observed with S518, 
the phosphorylation of T581 was much more 
pronounced in mitosis than during interphase 
(Figure 2D). Importantly, T581 phosphorylation 
was detected in mouse kidney extracts in the 
context of a proteomic screen of mouse 
phosphoproteins. pS518 was detected more 
frequently than pT581 
(https://phosphomouse.hms.harvard.edu/). This 
suggests that the phosphorylation of T581 might 
be limited compared to S518. 
The sequence surrounding T581 doesn't closely 
match any known kinase consensus site. When we 
treated the mitotically arrested Hela cells with 
MLN8054, there was no decrease of T581 
phosphorylation (Figure 2E) and Aurora A did not 
phosphorylate T581 in vitro indicating that this site 
is not a substrate for this kinase. We confirmed 
that T581 was not a substrate for Aurora B or C, or 
Slik. Also, Lats1/2 kinases, which were shown to 
interact with and be regulated by Aurora kinases 
(27) and that can bind the FERM domain of Merlin 
did not appear to phosphorylate Merlin during 
mitosis (Supplementary Figure 1B and 1C). Thus, 
it appears that T581 is the target of a kinase that is 
activated during mitosis and remains to be 
identified.  
Phosphorylation of S518 by Aurora A in mitosis 
facilitates the phosphorylation of T581 
It was previously shown that S518 phosphorylation 
facilitates the phosphorylation of S10, enabling 
Merlin degradation by the proteasome (28). We 
thus tested if phosphorylation of S518 and T581 
could influence each other. To do so, we compared 
the phosphorylation of each site, during mitosis, 
when the second site is mutated to an alanine (A) 
or to aspartic acid (D). Mutations of T581 had no 
impact on the phosphorylation of S518. However, 
T581 was more efficiently phosphorylated, when 
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S518 was changed for an aspartic acid as opposed 
to an alanine (Figure 2F-G). Hence our data show 
that phosphorylation of S518 facilitates the 
phosphorylation of T581 during mitosis. It is 
possible that S518 phosphorylation creates a new 
binding site for the kinase that targets T581. In 
addition, it is also conceivable that S518 
phosphorylation changes Merlin conformation 
facilitating the binding of a second kinase.  
Impaired phosphorylation of Merlin during 
mitosis delays metaphase exit 
Our results show that both S518 and T581 of 
Merlin are strongly phosphorylated during mitosis. 
We next investigated the consequences of the 
expression of double alanine (518A/581A- referred 
as AA hereafter) or aspartic acid substitutions 
(518D/581D- referred as DD hereafter) mutants in 
Hela cells during this phase of the cell cycle 
(Merlin mutants expression in Hela cells is shown 
in Supplementary Figure 1D). Using video 
microscopy (Figure 3A), their impact on mitotic 
progression was evaluated by measuring the 
interval between nuclear envelope breakdown 
(NEB) and the onset of anaphase (sister chromatid 
separation, SCS). A comparison has been made 
with uninduced Hela cells after we confirmed that 
wild-type Merlin overexpression had no effect on 
mitosis duration (Supplementary Figure 2). The 
expression of the dual aspartic acid mutant (DD), 
that mimics the doubly phosphorylated state of 
Merlin observed during mitosis, induced a very 
modest increase of the duration of NEB to SCS 
(Figure 3A lower panel, 3B right panel). The 
expression of the dual AA mutant, on the other 
hand, had a much more drastic effect, doubling the 
NEB to SCS transition time (Figure 3A upper 
panel, 3B left panel). More precisely, we could 
show that the longer mitosis is due to an increased 
duration of pro-metaphase to anaphase transition. 
Anaphase starts when the two centrosomes 
stabilize on the same plane at cellular poles 
providing an anchor for proper chromosomes 
separation (29, 30). Interestingly, we observed that 
the angle of the plane containing the two 
centrosomes to the plane of the adhesion surface 
(Figure 3 D) during metaphase is larger on average 
when the AA mutant is expressed. No such 
difference was observed with the DD mutant 
(Figure 3 E). This indicates that, at a given time 
during metaphase, the centrosomes are less likely 
to be on a plane parallel to the adhesion surface 
when AA mutant is expressed (Figure 3 F). In 
other words, it takes more time to align the 
centrosome in AA mutant-expressing cells, likely 
delaying anaphase onset. Thus, the double 
phosphorylation of Merlin appears necessary for 
mitosis to proceed and its absence delays the 
transition from NEB to SCS.  
Phosphorylation of Merlin on S518 and T581 
differentially inhibits binding to α-tubulin and 
Ezrin 
Merlin was shown to bind and to destabilize 
microtubules (24). When we examined the binding 
of α-tubulin to GFP-Merlin, we observed a strong 
interaction during interphase that is nearly 
abolished during mitosis (Figure 4A). Importantly, 
we observed that the DD mutant weakly interacts 
with α-tubulin in contrast to the strong binding of 
the AA mutant (Figure 4B and Supplementary 
Figure 3A). This suggests that the phosphorylation 
of Merlin during mitosis inhibits the interaction of 
Merlin with microtubules. It was previously 
observed that phosphorylation of S518 decreases 
the affinity of Merlin for α-tubulin (23). We used 
single mutant (A or D) of S518 and T581 to 
investigate their respective role in regulating 
Merlin/α-tubulin binding. Interestingly, we found 
opposite effects. As expected 518A mutant bound 
much better than 518D. However, 581D mutant 
bound strongly to α-tubulin compared to 581A 
(Figure 4B and Supplementary Figure 3B). Thus it 
appears that the phosphorylation of S518 controls 
the interaction with α-tubulin. Merlin isoform 2 
doesn't contain T581. We observed that it binds 
consistently better than isoform 1 to tubulin 
(Figure 4C). Nevertheless, the interaction is much 
weaker during mitosis  (Figure 4D) and also when 
S518 is changed for an aspartic residue compared 
to an alanine, demonstrating the same mode of 
regulation for both isoforms (Figure 4E). The 
observation that Merlin mutant T581D binds α-
tubulin better than T581A suggest that the former 
may harbor a different conformation making the 
FERM domain more accessible. This hypothesis is 
supported by the observation that isoform 2, which 
is expected to be under a more open conformation 
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resulting from the absence of interaction between 
the FERM and the C-ERMAD (C-terminal ERM 
association Domain) domains, also binds better to 
α-tubulin when compared to isoform 1. We then 
used co-immunoprecipitation assays between 
GST-Merlin-FERM and GFP-C-ter half of Merlin 
to test the effect of single and double phosphosite 
mutations on the intramolecular interaction (Figure 
4F left panel). As observed by Sher et al. (31), 
S518D mutation tends to increase the interaction. 
In contrast, T581D strongly weakens 
intramolecular interaction suggesting that 
phosphorylation of T581 may open Merlin isoform 
1 conformation. Dual DD and AA mutants showed 
barely any differences indicative of antagonistic 
effects. Merlin C-ERMAD also interacts with 
ERM FERM domain. Using the same strategy, we 
tested Merlin C-terminus interaction with Ezrin 
FERM domain (Figure 4F right panel). We did not 
observe a significant impact of S518 D or A 
mutation. However, the substitution of an alanine 
for T581 resulted in a dramatic increase in the 
interaction with Ezrin FERM domain when 
compared to aspartic acid substitution. Merlin AA 
mutant also bound better than the DD mutant 
indicating that phosphorylation of T581 is 
predominant for the regulation of Merlin/Ezrin 
interaction (Figure 4F right panel).  
ERM binds α-tubulin via their FERM domain and 
the interaction stabilizes microtubules at the cell 
cortex in the case of Moesin (19). We investigated 
if Merlin C-terminal domain may interfere with the 
binding of α-tubulin to the FERM domain of Ezrin. 
α-tubulin was coprecipitated with GFP-Ezrin in 
the presence or absence of Merlin C-terminal AA 
domain. As expected, Merlin C-terminal AA 
domain co-immunoprecipitated with GFP-Ezrin 
(Figure 5A). Interestingly, its expression 
stimulated the binding of α-tubulin to GFP-Ezrin. 
Actin binding to Ezrin was also stimulated under 
these conditions. Actin binds to the C-terminal end 
of Ezrin and our result suggests that the interaction 
of Merlin C-terminal domain with Ezrin may lead 
to a change in Ezrin conformation, exposing both 
the FERM and C-terminal domains for interaction 
(Figure 5A). 
To better understand the dynamics of Merlin and 
Ezrin mutual interaction and with α-tubulin during 
mitosis, we evaluated their phosphorylation state 
during M to G1 transition following nocodazole 
block release in Hela cells. The re-entry into G1 
was followed by FACS (Figure 5B) and the 
progression from metaphase to anaphase and 
telophase was followed by immunofluorescence 
and DAPI staining. We noticed that the kinetics of 
phosphorylation of S518 and T581 of Merlin are 
different. S518 phosphorylation shows a 
pronounced decrease at the onset of anaphase and 
upon G1 entry and parallels Aurora A expression. 
T581 phosphorylation dropped later corresponding 
to G1 entry. This could be a direct consequence of 
our observation showing that the phosphorylation 
of S518 facilitates T581 modification. In contrast, 
T567 phosphorylation of Ezrin, that leads to a 
more open conformation, was low in metaphase 
but reached a maximum 2 hours after release, 
corresponding to a strong enrichment of cells in 
telophase. Then, the signal decreased strongly 
upon G1 entry (Figure 5B). It is well established 
that T567 phosphorylation of Ezrin stimulates its 
binding to actin (32) but the impact on α−tubulin 
interaction was not clearly defined. Using GFP-
Ezrin mutants harboring either T567 D or A 
substitutions, we coprecipitated actin from 
HEK293 cells. We clearly confirmed the increased 
binding of actin to the T567D mutant. Interestingly, 
no difference was observed between A and D 
mutant for the binding to α-tubulin (Figure 5C 
right panels). We also confirmed the increased 
interaction of Ezrin with actin during mitosis 
(metaphase), using GFP trap. However, the same 
experiment showed a reproducible concomitant 
decrease in α-tubulin binding (Figure 5C left 
panels). In the end, we observed that actin binding 
to Ezrin was maximum two hours after nocodazole 
release (Figure 5D), likely a consequence of 
elevated T567 phosphorylation whereas α-tubulin 
interaction was rather low during mitosis and 
increased upon G1 entry, possibly resulting from 
increased binding of Merlin to the FERM domain 
of Ezrin. Our results thus show how 
phosphorylation events dynamically modulate 
Merlin and Ezrin interactions with α-tubulin and 
actin, necessary for mitosis progression, either 
directly or indirectly. 
Several NF2 patient mutations alter Merlin 
phosphorylation and α-tubulin binding 
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We next investigated if NF2 mutations identified 
in patients could modify Merlin phosphorylation 
on S518 and T581 and its binding to α-tubulin. We 
found that T581 phosphorylation was not affected 
by the mutations tested (Figure 6A). On the 
contrary, S518 phosphorylation was abolished in 
∂2-3 (lane3 and also Figure 1 I) and L64P mutants 
(lane 13), and reduced in K79E and Q324L (lane 4 
and 5) when compared to isoform 1 (all mutants 
are from isoform 1). Interestingly, this 
phosphorylation was consistently higher in isoform 
1 than in isoform 2 (lane 1 and 2).  We observed 
that mutants Q324L and L64P displayed increased 
tubulin binding (lane 5 and 13). As expected, the 
C-terminal half of Merlin showed no α-tubulin 
binding (lane 19). It also showed no 
phosphorylation on S518, which was expected 
since the binding region for Aurora A, like PAK1 
is localized in the FERM domain (4). Of interest, 
the absence of T581 phosphorylation suggests that 
the kinase binding site is also located in the N-
terminal half of Merlin. Mutations that would 
result in C-terminal truncation tended to decrease 
α-tubulin binding (M1-480 and M1-532 lanes 17 
and 18). However, the sequence M1-330 
corresponding to the FERM domain displayed 
higher binding than the full lengh Merlin likely 
due to the absence of masking from the C-terminal 
sequence. Finally, we tested the impact of L64P 
and Q324L mutants on mitosis duration because 
both of them showed elevated α-tubulin binding. 
Q324L slightly shortened mitosis but L64P slowed 
mitosis to a similar extent as Merlin AA mutant 
(Figure 6B and Supplementary Figure 4). In 
addition, upon L64P expression, about 13% of 
cells that started mitosis were unable to reach 
telophase after several hours and died. These 
results suggest that both α-tubulin binding and 
S518 dephosphorylation are required to induce a 
delay in mitotic progression. However, we cannot 
exclude that these mutations of Merlin eventually 
delay mitosis progression by other mechanisms. 
Thus, we confirm that several NF2 patient 
mutations alter Merlin phosphorylation state and 
α-tubulin binding. Although the two events appear 
largely independent in this case, our data indicate 
that the expression of a subset of mutants of 
Merlin found in patients is likely to interfere with 
mitotic progression. 
Discussion 
The major function of Merlin is to inhibit cell 
proliferation, notably in response to cell-cell 
contacts. Most studies have shown that Merlin 
exerts its tumor suppressor role primarily by 
inhibiting important mitogenic signaling pathways 
(33-38). However, some recent evidences of its 
implication in cell cycle progression have emerged. 
In this report, we show that Merlin 
phosphorylation is likely necessary for a proper 
progression from metaphase to anaphase and 
correct spindle positioning. This could be due to its 
capacity to modulate Merlin interaction with   
α-tubulin. Indeed, Merlin was reported to bind to 
microtubules, promoting their stabilization (24) but 
the functional consequences were not explored. 
During mitosis, Merlin could play a role analogous 
to Ezrin which binding to α-tubulin stabilizes aster 
microtubules ensuring correct positioning of the 
centrosomes (21). A role for Merlin during mitosis 
was also proposed although through a very 
different mechanism. Hebert et al. showed that 
Merlin restricts Ezrin cortical distribution so that, 
upon activation during mitosis, Ezrin directs the 
correct positioning of the centrosomes and proper 
orientation of mitotic spindles (18) necessary for 
the establishment of epithelial architecture. Thus, 
Merlin may influence mitotic progression by 
modulating Ezrin functions. Interestingly, it was 
also reported that a correct polarized localization 
of NuMa is necessary for proper spindle 
orientation in mitosis and requires the local 
activation of Ezrin by the Slk kinase (39). The 
expression of a constitutively active form of Ezrin 
leads to an unpolarized recruitment of NuMa and a 
defect in spindle orientation in mouse apical 
progenitor, resulting in the same spindle 
orientation defect that we observed in Hela cells 
expressing the Merlin AA mutant. The expression 
of Merlin AA mutant stimulates the interaction of 
Ezrin with α-tubulin and actin, equivalent to the 
activation of Ezrin by phosphorylation. It is thus 
conceivable that Merlin AA expression induces an 
unpolarized activation of Ezrin perturbing NuMa 
recruitment and leading to spindle misorientation. 
However, the alteration of the binding of α-tubulin 
and actin to Ezrin induced by Merlin AA might 
also be involved in the phenotype. 
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Hence, our results indicate that Merlin likely plays 
an important role during cell division through 
distinct mechanisms. They underline the 
importance of the interplay between Merlin and 
Ezrin for a proper progression of mitosis that was 
suggested in other studies (18, 40).  
In addition, we observed that several patient 
mutations lead to altered phosphorylation of 
Merlin and tubulin binding. The two effects, 
however, were not necessarily linked. This 
suggests that the mutations also likely induce 
changes in Merlin conformation independently 
affecting the binding of the kinase and to α-tubulin. 
Thus, in contrast to WT Merlin, specific mutants 
can still bind to α-tubulin and Ezrin during mitosis 
and could act as a gain of function mutants 
inducing a delay in mitotic progression. 
Interestingly, such delays were previously linked 
to an increased risk of DNA damage by various 
mechanisms (41). They usually lead to genomic 
instability and favor either tumorigenesis or 
apoptosis. Point mutations have in general been 
linked to milder forms of NF2 (42-44) and our 
results thus support the idea that mutations 
disturbing Merlin phosphorylation in mitosis 
trigger cell death and protect from tumor 
development to a certain point. This seems to be 
the case for the L64P mutant which strongly delays 
mitosis completion and induces cell death in a 
large subset of mitotic cells. It would be of interest 
to know if L64P mutants are associated to a milder 
for of the disease. However, severe phenotypes 
associated to point mutations were also reported 
(45) indicating that the outcome is linked to the 
nature of the mutation.  
Several studies reported that isoform 2 does not 
inhibit cell proliferation (46) conflicting with other 
publications (47-49). Mice engineered to express 
either isoform 1 or 2 both developed normaly and 
were protected from tumor development (50) 
demonstrating their functional redundancy. 
Nevertheless, the same study reported functionnal 
differences, as isoform 2 was uniquely involved in 
the maintenance of axonal integrity. We uncovered 
a new phosphorylation site that is specific to 
isoform 1. T581 phosphorylation abolishes Merlin 
C-terminal interaction with Ezrin FERM domain 
and promotes Merlin binding to α-tubulin. It also 
decreases Merlin head to tail interaction (Figure 
4F) and is more likely to participate in Merlin open 
conformation than S518 phosphorylation, in 
coherence with results reported recently (51, 52) 
Interestingly this phosphorylation confers to 
isoform 1 interaction properties that are similar to 
those of isoform 2. Indeed, isoform 2 doesn’t 
interact with Ezrin Ferm domain via its C-terminal 
end and binds more efficiently to α-tubulin than 
isoform 1 via its FERM domain. Hence, during 
mitosis, T581 phosphorylation prevents Merlin 
1/Ezrin interaction while Merlin 2 is not 
interacting anyway. However, this modification 
alone would promote tubulin binding but is 
superseded by S518 phosphorylation which 
inhibits this interaction for both isoforms. Thus, 
our results show that soform I have additional 
means of regulating its binding to specific 
molecular partners, compared to isoform 2. In 
summary, although isoform 1 and 2 exert 
essentially the same molecular functions, these can 
be differentially regulated by phosphorylation 
depending on the cellular context. This could 
explain the absence of functional redundancy that 
was sometimes observed in cells and mice when 
both isoforms are expressed.   
In summary, we have uncovered a potential novel 
function of Merlin as a regulator of mitotic 
progression. Merlin is a bona fide substrate for the 
mitotic kinase Aurora A. Its phosphorylation and 
subsequent release from microtubules and from 
Ezrin appear to be required for mitosis to proceed 
correctly (Figure 7). Our results suggest that, in 
wild-type cells, specific mutations on a single 
allele of NF2 could result in the production of a 
Merlin mutant with altered phosphorylation and 
binding to α−tubulin and Ezrin acting dominantly 
and influencing the early stages of tumorigenesis. 
It would be of great interest to evaluate how the 
severity of the disease is linked to the capacity of a 
point mutation to alter Merlin function during 
mitosis. However, the rarity of the disease and the 
diversity of NF2 mutations may render this study 
difficult to perform. 
Experimental procedures 
Plasmids constructs: GFP-Merlin expression 
vectors were constructed by inserting the cDNA of 
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isoform 1, 2 and patients derived mutants (kindly 
provided by Joseph Kissil, Scripps Research 
Institute, Florida) into pEGFPC1 (Clonetech).  
Cell culture: Human embryonic kidney (HEK293) 
cells and Hela cells were cultured in DMEM 
medium supplemented with 10% FBS, penicillin 
(500 units/mL) and streptomycin (500 µg/ml) 
antibiotics (all Gibco, Life technologies, France) at 
37°C with 5% CO2. 
Inducible cell lines: Hela cell lines inducible 
expressing Merlin mutants were generated using 
the RetroX Tet On advanced inducible system 
(Clonetech) following manufacturer guidelines. 
The expression of Merlin mutants was confirmed 
by immunofluorescence. 
Cell synchronization in mitosis and drug 
treatments: Following 16h treatment with 
0.5µg/ml Nocodazole, mitotic Hela cells were 
detached and collected by shaking the plate, Cells 
still attached represented the interphasic fraction. 
The Aurora A and B inhibitors (MLN8054, 
ZN4474, Sigma-Aldrich) were added at 1 µg/ml 
for 1 hour to the culture media of cell blocked in 
mitosis with nocodazole. MG132 was added at 1 
µM to prevent exit from mitosis. 
Timelapse and mitosis duration experiments: 
Hela inducible cells were plated in 
DMEM+10%FBS with or without Doxycycline 
1µg/ml, in 3 cm Fluorodish (World Precision 
Instruments). Video acquisition started 8h after 
release from a 16h block in S phase with 2mM 
thymidine (with or without doxycycline) at 37°C, 
and 5% CO2 with Nikon video microscope using 
40X (NA 1.3) DIC oil objective and binning2. One 
image was taken every 2 min for 20h. For each 
experiment, 2 to 4 acquisitions were sequentially 
performed for each condition (+ or - doxycycline) 
and the data were pooled. Video analysis was done 
with ImageJ software and duration was calculated 
with tracking plugin.  
 
Measurements of angles during metaphase: 
Fixed metaphasic cells overexpressing or not 
mutant Merlin AA (39 cells) or DD (43 cells) were 
stained for Merlin, α-tubulin and DNA (DAPI). 
Images were acquired with a Zeiss Axio-observer 
Z1 microscope, controlled by axiovision software 
and with a Hammatsu Camera using a 63X 
immersion oil objective, 1.40 plan apo and 1.6 
optovar and binning1. Voxels were collected at 
64nm lateral and 240nm axial intervals, followed 
by deconvolution using the Huygens software. The 
distance between the planes containing the 
centrosomes (in µm) was calculated as ∆z=n*0,24 
were n is the number of focal planes separating the 
two centrosomes. The angle of the plane 
containing the centrosomes to the adhesion plane 
was calculated as a=arctan(∆z/d) were d is the 
projected distance between the two centrosomes 
(in µm). Measurements were made with Icy 
software.  
 
FACS analysis: Hela cells released from 
nocodazole block were fixed in paraformaldehyde 
4% for 10 minutes followed by a permeabilization 
in PBS + 0.2% Triton X100 for 10 minutes, 
stained with DAPI at 1µg/ml and the DNA content 
was measure by FACS on a Guava EasyCyte flow 
cytometer (Merck Millipore). In parallel, a subset 
of cells were plated on coverslips, fixed and 
stained under the same conditions. Each timepoint 
was evaluated for enrichment in cells in metaphase 
or telophase to document the progression through 
mitosis using a Leica DM 6000B epifluorescence 
microscope and a 63X (NA 1.4) oil immersion 
objective. 
 
Immunofluorescence and microscopy:  Cells 
were seeded seeded on glass coverslips and fixed 
in 4% paraformaldehyde for 10 minutes followed 
by a permeabilization in PBS + 0.2% Triton X100 
for 10 minutes. Incubation with primary antibody 
was done in PBS + 0.1% Tween 20 + 10 % FBS, 
overnight at +4C. The secondary antibodies were 
incubated in the same buffer for 2 hours at room 
temperature together with DAPI at 1µg/ml. Images 
were acquired on a Leica DM 6000B 
epifluorescence microscope and a 40X (NA 1.3) or 
a 63X (NA 1.4) oil immersion objective.  
 
GFP trap: Cell lysates were prepared and 
incubated overnight with GFP-Trap beads 
(ChromoTek, Deutschland) following 
manufacturer's instructions.  
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Western-blotting and quantification: Between 
20 to 40µg of protein extracts were loaded on 
NuPage 4-12% bis-tris gels in MES migration 
buffer (Invitrogen). The transfer was performed 
using Iblot gel transfer stack Nitrocellulose 
(Invitrogen). Membrane were usually blocked with 
5% low fat milk in Tris Buffered Saline plus 0,5% 
Tween20 Buffer (TBST) for 20 minutes. Primary 
antibody was incubated with the membrane 
overnight at +4°C in TBST+10%FBS. Following 
three 10 minutes rinses in TBST, the membranes 
were incubated with secondary Horse radish 
peroxidase (HRP) labelled antibodies (Amersham) 
for one hour at room temperature. After three 
additionnal 10 minutes rinses in TBST, the 
membranes were incubated with developping 
solution (SuperSignal West Pico, Thermofisher). 
Then, signal intensities of blotting images were 
analyzed by imaging software (Bio-Rad Image lab 
v 4.0.1) using manufacturer’s procedure. Briefly, 
the same size of pixel area was selected and signal 
intensity calculated by subtraction the background 
signal. Each signal was normalized with reference 
to standard control signals, e.g. actin or total 
protein (when analyzed for phospho-proteins), and 
a signal/control ratio was calculated. 
Antibodies: Ezrin antibody was a kind gift from 
Monique Arpin. Cell Signaling: Aurora A (14475), 
phospho Aurora A T288 (2914), phospho Aurora 
B T232 (2914), phospho Ezrin T567 (3141). Santa 
Cruz: Merlin (C-18 SC-332 and N-19 SC-331), 
GFP (SC-8334 and SC-9996) Sigma: actin 
(A2228), α-tubulin (T9026). Rockland: phospho 
Merlin S518 (600-401-414). Covalab (Lyon, 
France): Merlin (pab0939p). 
Generation of pT581 Merlin antibody: The 
AERTYGDVERA peptide phosphorylated on the 
threonine was coupled to albumin. Rabbit 
immunization and purification against 
phosphorylated and non-phosphorylated peptides 
were done by Covalab (Lyon, France). 
Merlin in vitro phosphorylation assay: GFP-
Merlin WT and S518A immunoprecipitated by 
GFP Trap from HEK293 were treated with 50 
units of Calf Intestinal Alkaline Phosphatase 
(Biolabs) at 30°C for 2 hours in phosphatase buffer 
and washed 3 times with kinase buffer. One 
microgramme of purified Aurora A kinase 
(Millipore, 14-511) was added to the beads for one 
hour at 30°C. The reaction was stopped with 
Laemmli buffer at 95°C for 10 minutes. 
Proteomics and Mass spectrometry: GFP tagged 
Merlin was immunoprecipitated from HEK293, 
separated by SDS-PAGE and visualized with 
commassie staining, after which the protein bands 
were cut out from the gel, digested with trypsin 
into peptides, and analyzed by liquid 
chromatography–tandem mass spectrometry (LC-
MS/MS) using an Ultimate 3000 nano-LC (Dionex, 
Sunnyvale, CA) coupled to an LTQ Orbitrap XL 
mass spectrometer (Thermo scientific/MDS Sciex, 
Foster City, CA). The fragmentation spectrum is 
derived from a tryptic (1 missed cleavage) Merlin 
peptide.  
In vitro Merlin/Ezrin and Merlin/Merlin 
interactions: GFP tagged Merlin constructs 
precipitated from HEK293 by GFP trap were 
incubated for 3h at 4°C with his tagged purified 
Ezrin FERM domain or purified GST Merlin. 
After 6 rinses in lysis buffer (20mM Hepes, 
100mM NaCl, 0.5mM EDTA, 0.1% tritonX100, 
PIC 1/100 Sigma), beads were resuspended in 
loading buffer and protein complex were analyzed 
by western-blot.
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Figure 1 
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Figure 1: Merlin is a substrate for Aurora A on Serine 518 during mitosis. (A) The sequence of amino 
acids around serine 518 closely matches Aurora A target sequences. (B) GFP-Merlin (WT) and GFP-
Merlin 518A were immunopurified from HEK293, dephosphorylated with alkaline phosphatase and 
incubated with recombinant Aurora A (+) or with the kinase buffer alone (-). The phosphorylation of S518 
was detected using an antibody specific to the phosphorylated site. (C) The phosphorylation of S518 is 
higher in extracts from mitotic Hela cells overexpressing Merlin compared to interphasic cells. The 
quantification of 3 independent experiments is shown on the right graph (a.u= arbitrary units). (D) Mitotic 
Hela cells overexpressing Merlin were treated with the Aurora A inhibitor MLN 8054. The 
phosphorylation of Merlin on S518 and the activity of Aurora A (phosphorylation of T288) are strongly 
inhibited. (E) Mitotic (+ nocodazole) Hela cells overexpressing Merlin (M) were treated with Aurora A 
inhibitor (MLN8054) or Aurora B inhibitor (ZM4474) in the presence of MG132 proteasome inhibitor. 
Only MLN8054 inhibited phosphorylation on S518. Interphasic cell extract (I) is presented for 
comparison (- nocodazole). (F) Endogenous Merlin (M) was immunoprecipitated from extracts of mitotic 
HEK293 cells treated or not with MLN 8054. The samples were probed with antibodies to Merlin or p-
Merlin S518. Non-specific antibody was use as a negative control (IgG). Quantification is presented on 
the right graph (3 experiments). (G) Co-immunoprecipitation using GFP fusion of Merlin full length (WT), 
Merlin Ferm domain (FERM, 1-330) or Merlin C-terminal half (330-595, C-ter) demonstrate that Merlin 
interacts with Aurora A via its Ferm domain. TCE-Total cell extract. (H) A patient mutant of Merlin Ferm 
domain skipping exon 2 and 3 (∆2-3, aa 38 to 121) fails to bind to Aurora A as observed by co-
immunoprecipitation. (I) ∆2-3mutant is not phosphorylated on S518 when expressed in mitotic Hela cells. 
Actin was used as loading control throughout. All blots shown above are representative of three 
independent biological experiments (n = 3). Error bars represent ±S.D. 
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Figure 2 
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Figure 2: Threonine 581 of Merlin isoform 1 is phosphorylated during mitosis. (A) Mass 
spectrometry analysis of HEK293 cells overexpressing wild-type Merlin isoform 1 identifies a peak 
corresponding to a peptide phosphorylated on threonine 581. The peptide sequence and the observed ions 
of the phospho-peptide are shown with the spectrum. MS/MS spectrum is labeled to show singly charged 
b and y ions, as well as ion corresponding to neutral losses of water (o), NH3 (*) and H3PO4 group 
(98Da). LC-ESI MS/MS spectrum for peptide with the position of the phosphate group KLpT (581) 
LQSAK (484.762+ m/z). (B) The comparison of Merlin Isoform 1 and 2 sequences C-terminal to amino 
acid 570 show that T581 is unique to Isoform 1. (C) An antibody raised against a peptide including 
phospho-T581 recognizes Merlin overexpressed in HEK293 but doesn't recognized Merlin S518/T581A 
mutant (AA), proving good specificity. Specificity of the antibody to S518 was checked in parallel. (D) 
T581 is highly phosphorylated during mitosis in Hela cells overexpressing Merlin. The quantification of 3 
independent experiments is shown on the right panel. (E) The treatment of mitotic Hela cells with 
MLN8054 has no impact on T581 phosphorylation. (F) The influence of alanine and aspartic substitutions 
of S518 or T581 on the phosphorylation level of the other site was evaluated by western-blot on extract 
from mitotic Hela cells. The S518A substitution clearly reduces the phosphorylation of T581 compared to 
S518D. There is no impact of T581A and D substitutions on S518 phosphorylation levels. (G) 
Quantification of 3 independent experiments corresponding to the conditions used in panel F. The ratio of 
phosphorylated Merlin to total Merlin is presented. Actin was used as loading control. All blots shown 
above are representative of three independent biological experiments (n = 3). Error bars represent ±S.D. 
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Figure 3 
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 Figure 3: Phosphorylation of Merlin is necessary for mitotic progression. (A) The induced expression 
of a double alanine mutant of Merlin (S518A-T581A) strongly increases the interval between nuclear 
envelope breakdown (NEB, black arrowhead) and anaphase (white arrowhead) as observed by DIC 
microscopy. In contrast, the double aspartic mutant (S518D-T581D) doesn't. Size bar=30µm. The 
statistical analysis was done using Mann Whitney test on R Software. (B) The quantification of 
experiments such as presented in A shows that Merlin dual alanine mutant doubles the duration of NEB to 
anaphase. The induction of the phosphomimetic mutant has only a minor impact. (C) Phase contrast 
microscopy analysis reveals that mitotic delay is the result of a prolonged metaphase. (D) The angle of the 
plan going through the centrosome to the horizontal was measured during metaphase by combining α-
tubulin staining and confocal microscopy on Merlin AA and DD overexpressing Hela cells. (E) The 
expression of Merlin AA but not Merlin DD mutant results in an increased frequency of higher angles. (F) 
Quantification of the average angle of the mitotic spindle plan to the horizontal in Hela cells shows a 
significant increase upon Merlin AA mutant expression. One-way ANNOVA:  ns: p>0.05, *: p<0.05, **: 
p<0.01. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 by guest on A
ugust 13, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Merlin regulates mitotic progression   
 
 20 
Figure 4 
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Figure 4: Phosphorylations of Merlin modulate its interaction with α-tubulin and with Ezrin. (A) In 
Hela cells, α-tubulin coprecipitate with GFP-Merlin isoform 1 from interphasic extracts (I) but much less 
from mitotic extracts (M). (B) Coprecipitation from interphasic Hela cell extracts show that S518D 
substitution prevent α-tubulin interaction. In contrast, T581D substitution promotes the interaction. 
Double AA and DD mutants coprecipitation experiments show that S518 substitution is dominant over 
T581. (C) Merlin isoform 2 (Iso2) interacts more strongly with α-tubulin than isoform 1 (Iso1) in Hela 
interphasic extracts. (D) As observed for Merlin isoform 1, GFP-Merlin isoform 2 binding to α-tubulin 
strongly decrease during mitosis but the overall binding is higher than for Isoform 1. (E) S518D 
substitution inhibits Merlin isoform 2 interaction with α-tubulin assessed by coimmunoprecipitation from 
Hela interphasic extracts. Average relative α-tubulin binding from at least 3 experiments is indicated. (F) 
S518D substitution stimulates the binding of GFP-C-ter. Merlin (330-595) isoform 1 to purified GST N-
ter Merlin (1-330). T581D substitution inhibits the interaction compared to T581A substitution. AA and 
DD C-terminal Merlin show minimal difference in binding to N-ter Merlin (left panel). Remarkably, the 
alanine mutation of T581 greatly facilitates the binding of the C-terminal half of Merlin fused to GFP to 
the his-tagged FERM domain of Ezrin, when compared to the T581D substitution. The binding is even 
stronger when S518 is also mutated to an alanine (AA) (right panel). The blot shows the quantity of bait 
protein used (GFP constructs) and the amount of interacting Merlin or Ezrin N-ter protein precipitated. All 
experiments were repeated at least 3 independent times. Student t-test. ns: p>0.05, *: p<0.05, **: p<0.01, 
***: p<0.001. Error bars represent ±S.D. GFP was used as a control. 
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 Figure 5 
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Figure 5: Merlin and Threonine 567 phosphorylation modulate Ezrin interaction with the 
cytoskeleton during mitosis. (A) Merlin C-ter AA domain binds to Ezrin and stimulates its interaction 
with α-tubulin and actin. Merlin C-ter AA domain was co-expressed (+) or not (-) with GFP-Ezrin in Hela 
cells. Bound α-tubulin and actin were evaluated by western-blot following precipitation of GFP-Ezrin. (B) 
The expression and phosphorylation of Merlin (S518 and T581), Ezrin (T567) and Aurora A were 
evaluated by western-blot following the release of Hela cells from nocodazole block. Actin was used as 
loading control. The progression from mitosis (metaphase and telophase, 2N cells) to G1 (1N cells) was 
followed by FACS and by microscopy using DAPI staining (upper bar graph). The timeframe showing the 
progression of the cells through metaphase and telophase, assessed by DAPI staining, is shown under the 
blots. (C) Immunoprecipitation of GFP-Ezrin shows that its binding to α-tubulin decreases whereas 
interaction with actin increases during mitosis compared to interphase. In addition, T567D substitution 
stimulates actin binding of Ezrin but has no impact on α-tubulin interaction, when compared to T567A 
substitution. A quantification of 3 independent experiments is provided. Student t-test: ns: p>0.05, *: 
p<0.05, **: p<0.01, ***: p<0.001. (D) The binding of actin and α-tubulin to GFP-Ezrin was followed by 
coimmunoprecipitation during the transition from mitosis to G1 following release from nocodazole block 
in Hela cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 by guest on A
ugust 13, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Merlin regulates mitotic progression   
 
 24 
 Figure 6 
 
 by guest on A
ugust 13, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Merlin regulates mitotic progression   
 
 25 
Figure 6: Several patient mutations affect Merlin phosphorylation state and/or the binding to α-
tubulin. (A) The binding of α-tubulin and the phosphorylation state of S518 and T581 of Merlin isoform 
1 and 2, truncation mutants as well as several patient missense mutants were evaluated using HEK293 
cells transfected with GFP-Merlin constructs. The expression level of the constructs is presented in the 
upper panel (probed with anti-GFP antibody). The list of constructs used is indicated below the western-
blots. GFP was used as IP control throughout. (B) Merlin Q324L expression in Hela cells leads to a 
limited shortening of mitosis duration. In contrats, L64P mutant strongly delays NEB to telophase 
progression in a way very similar to Merlin S518A-T581A mutant (Figure 3A&B). Mann Whitney test on 
R Software. 
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Figure 7 
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